Access Bio Signs Supply Contract for COVID-19 Antigen Test Kits Worth 4.7 Billion KRW

[Asia Economy Reporter Geum Bo-ryeong] Access Bio announced on the 20th that it has signed a supply contract worth 4.7 billion KRW for a novel coronavirus (COVID-19) antigen diagnostic kit with Intrivo Diagnostics.

The contract amount is 10.98% of last year's consolidated sales. The contract end date is the 16th of next month.